FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894440401> ?p ?o ?g. }

• W2894440401 endingPage "114" @default.
• W2894440401 startingPage "107" @default.
• W2894440401 abstract "Low levels of AEDs can be secondary drug–drug interactions or related to irregular intake due to poor treatment adherence. This latter behavior is highly suspected in ambulatory pediatric epileptic patients when controls of AEDs are subtherapeutic. However, it cannot be considered for inpatients during long periods of hospitalization. A few isolated case reports have documented persistent low levels (PLL) of AEDs in hospitalized epileptic children, but no population study has currently been reported. The aim of this study was to document the incidence of PLL of the most common AEDs – phenytoin (PHT), phenobarbital (PHB), valproic acid (VA), and carbamazepine (CBZ) – in pediatric epileptic in- and outpatients (PEP). 21,040 plasma levels of the aforementioned AEDs from 3279 PEP were retrospectively analyzed. Plasma levels of AEDs were measured by an automated method using trademarked commercial kits with their corresponding quality control programs. Randomized samples were also controlled by HPLC methods. Only cases with more than 3 controls were included in the study. A high rate of PLL of PHT was detected in in- (71.7%) and outpatients (74.1%), while PLL of PHB, VA, and CBZ were detected in a lower proportion. Rates of PLL of PHT were similar in in- and outpatients. PLL of PHB was more commonly observed in outpatients while PLL of VA and CBZ were more frequently seen in inpatients. In some hospitalized patients receiving polytherapy, PLL of at least one AED were documented during a long time. Treatment non-adherence could be present in part of the outpatients, but cannot explain the PLL observed in a group of inpatients as described here. The recently described “pharmacokinetic hypothesis” of pharmaco-resistant epilepsy should be addressed in cases with AEDs-PLL, particularly in hospitalized cases. Perhaps, instead of stopping the subtherapeutic medication, the increasing doses of this AED and/or administration of inhibitors of CYP and P-glycoprotein, could help to achieve its therapeutic range, allowing a better pharmacologic effect and avoiding the development of more severe complications, such as status epilepticus or SUDEP." @default.
• W2894440401 created "2018-10-05" @default.
• W2894440401 creator A5018185234 @default.
• W2894440401 creator A5051859402 @default.
• W2894440401 creator A5052210949 @default.
• W2894440401 creator A5062950941 @default.
• W2894440401 creator A5078478495 @default.
• W2894440401 creator A5087715909 @default.
• W2894440401 date "2018-12-01" @default.
• W2894440401 modified "2023-09-30" @default.
• W2894440401 title "High incidence of persistent subtherapeutic levels of the most common AEDs in children with epilepsy receiving polytherapy" @default.
• W2894440401 cites W1431013371 @default.
• W2894440401 cites W1571533074 @default.
• W2894440401 cites W1967132667 @default.
• W2894440401 cites W1969923380 @default.
• W2894440401 cites W1971152586 @default.
• W2894440401 cites W1986245831 @default.
• W2894440401 cites W1993155812 @default.
• W2894440401 cites W1997125463 @default.
• W2894440401 cites W1997520975 @default.
• W2894440401 cites W2009257300 @default.
• W2894440401 cites W2027150001 @default.
• W2894440401 cites W2027177883 @default.
• W2894440401 cites W2029440281 @default.
• W2894440401 cites W2031260232 @default.
• W2894440401 cites W2031706263 @default.
• W2894440401 cites W2033614870 @default.
• W2894440401 cites W2035448237 @default.
• W2894440401 cites W2058985568 @default.
• W2894440401 cites W2060587811 @default.
• W2894440401 cites W2072577512 @default.
• W2894440401 cites W2077355747 @default.
• W2894440401 cites W2079476893 @default.
• W2894440401 cites W2084315864 @default.
• W2894440401 cites W2085018008 @default.
• W2894440401 cites W2086215916 @default.
• W2894440401 cites W2088129118 @default.
• W2894440401 cites W2092647329 @default.
• W2894440401 cites W2095335567 @default.
• W2894440401 cites W2098705403 @default.
• W2894440401 cites W2099570512 @default.
• W2894440401 cites W2101347950 @default.
• W2894440401 cites W2107333830 @default.
• W2894440401 cites W2119568657 @default.
• W2894440401 cites W2120944874 @default.
• W2894440401 cites W2122268046 @default.
• W2894440401 cites W2123479820 @default.
• W2894440401 cites W2123729609 @default.
• W2894440401 cites W2129406235 @default.
• W2894440401 cites W2133500154 @default.
• W2894440401 cites W2137797742 @default.
• W2894440401 cites W2147917303 @default.
• W2894440401 cites W2149974939 @default.
• W2894440401 cites W2159227093 @default.
• W2894440401 cites W2160246128 @default.
• W2894440401 cites W2164408902 @default.
• W2894440401 cites W2167849700 @default.
• W2894440401 cites W2167863485 @default.
• W2894440401 cites W2331187269 @default.
• W2894440401 cites W2470709485 @default.
• W2894440401 cites W2550290765 @default.
• W2894440401 cites W2620218661 @default.
• W2894440401 cites W2744115661 @default.
• W2894440401 cites W2794992337 @default.
• W2894440401 cites W4323894828 @default.
• W2894440401 cites W71804698 @default.
• W2894440401 cites W2412648478 @default.
• W2894440401 doi "https://doi.org/10.1016/j.eplepsyres.2018.09.008" @default.
• W2894440401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30279018" @default.
• W2894440401 hasPublicationYear "2018" @default.
• W2894440401 type Work @default.
• W2894440401 sameAs 2894440401 @default.
• W2894440401 citedByCount "10" @default.
• W2894440401 countsByYear W28944404012019 @default.
• W2894440401 countsByYear W28944404012021 @default.
• W2894440401 countsByYear W28944404012022 @default.
• W2894440401 countsByYear W28944404012023 @default.
• W2894440401 crossrefType "journal-article" @default.
• W2894440401 hasAuthorship W2894440401A5018185234 @default.
• W2894440401 hasAuthorship W2894440401A5051859402 @default.
• W2894440401 hasAuthorship W2894440401A5052210949 @default.
• W2894440401 hasAuthorship W2894440401A5062950941 @default.
• W2894440401 hasAuthorship W2894440401A5078478495 @default.
• W2894440401 hasAuthorship W2894440401A5087715909 @default.
• W2894440401 hasConcept C118552586 @default.
• W2894440401 hasConcept C120665830 @default.
• W2894440401 hasConcept C121332964 @default.
• W2894440401 hasConcept C126322002 @default.
• W2894440401 hasConcept C187212893 @default.
• W2894440401 hasConcept C2777138316 @default.
• W2894440401 hasConcept C2777172819 @default.
• W2894440401 hasConcept C2777683783 @default.
• W2894440401 hasConcept C2778186239 @default.
• W2894440401 hasConcept C2778337148 @default.
• W2894440401 hasConcept C2778793413 @default.
• W2894440401 hasConcept C2779253243 @default.
• W2894440401 hasConcept C2908647359 @default.
• W2894440401 hasConcept C35785553 @default.

• next